Aligos Therapeutics’ $83.6 Million Public Offering

Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering.Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced the…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now